Apollo Hospitals is one of India’s largest and most trusted healthcare providers, known for offering world-class medical services across a wide range of specialties. Established in 1983, the company has played a key role in transforming healthcare in India and is recognized for its high-quality care, advanced medical technology, and patient-centric approach. With a strong presence both in India and abroad, Apollo Hospitals has earned a reputation for excellence in healthcare delivery and innovation. As of December 6, 2024, the Apollo Hospitals share price on the NSE is ₹7,228. Below are the projected Apollo Hospital share price target for the years 2024, 2025, 2026, 2027, 2030, 2035 And 2040.
Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360
Apollo Hospitals Limited Company Overview
Headquartered in Chennai, India, Apollo Hospitals operates a vast network of multi-specialty hospitals, clinics, pharmacies, and diagnostic centers across India and several other countries. The company offers a wide range of healthcare services, including tertiary and quaternary care, emergency services, organ transplantation, and advanced treatments in fields such as cardiology, oncology, orthopedics, neurology, and pediatrics. Apollo Hospitals is a pioneer in bringing advanced healthcare technologies and international best practices to India.
| Trade name | Apollo Hospitals |
| Company type | Public |
| Traded as | BSE: 508869 NSE: APOLLOHOSP |
| ISIN | INE437A01024 |
| Industry | Healthcare |
| Founded | 18 September 1983; 41 years ago |
| Founders | Prathap C. Reddy |
| Headquarters | Chennai, Tamil Nadu, India |
| Areas served | South Asia Middle East |
| Key people | Prathap C. Reddy (Chairman) Preetha Reddy (Executive Vice Chairperson) Suneeta Reddy (Managing Director) Sangita Reddy (Joint Managing Director) |
| Products | Hospitals Pharmacy Diagnostic Centres Home care |
| Revenue | ₹20,469 crore(FY24) |
| Operating income | ₹2,745 crore(FY24) |
| Net income | ₹1224 crore(FY24) |
| Total assets | ₹19,548 crore(2024) |
| Number of employees | 62,939 (2020) |
| Website | www.apollohospitals.com |
Apollo Hospital Share Price Target 2025-2040 Forecast
| Year | Year High Target (₹) | Year Low Target (₹) | Year-End Target (₹) |
| 2024 | ₹7550 | ₹5250 | ₹7400 |
| 2025 | ₹8100 | ₹5900 | ₹7750 |
| 2026 | ₹8750 | ₹6850 | ₹8300 |
| 2027 | ₹9400 | ₹7200 | ₹9050 |
| 2028 | ₹10500 | ₹8500 | ₹9850 |
| 2029 | ₹11750 | ₹9100 | ₹10900 |
| 2030 | ₹13250 | ₹10200 | ₹12400 |
| 2035 | ₹19600 | ₹11350 | ₹18250 |
| 2040 | ₹25450 | ₹17100 | ₹22500 |
Technical Analysis for Apollo Hospitals
Apollo Hospital Share Price Target 2025
| Year | 1st Target | 2nd Target |
| 2025 | ₹7850 | ₹8100 |
Apollo Hospitals is expected to experience strong growth in 2025, benefiting from its expansive network and premium healthcare services. The share price is projected to reach a first target of ₹7850 and a second target of ₹8100, reflecting its continued success in the healthcare sector.
Read More:- Niva Bupa Share Price Target 2025, 2030, 2035, 2040
Apollo Hospitals Share Price Target 2026
| Year | 1st Target | 2nd Target |
| 2026 | ₹8550 | ₹8750 |
In 2026, the company is expected to capitalize on increasing healthcare demand and its continued innovations in patient care. The share price is forecasted to hit ₹8550 for the first target and ₹8750 for the second target, driven by its industry-leading services.
Apollo Hospital Share Price Target 2027
| Year | 1st Target | 2nd Target |
| 2027 | ₹9150 | ₹9400 |
By 2027, Apollo Hospitals is anticipated to further solidify its position in the healthcare sector through strategic expansions and improved service offerings. The share price is expected to reach ₹9150 for the first target and ₹9400 for the second target.
Apollo Hospital share price target forecast 2028
| Year | 1st Target | 2nd Target |
| 2028 | ₹10100 | ₹10500 |
In 2028, the company’s focus on technology and expanding its footprint is expected to drive significant growth. The share price is projected to reach ₹10,100 for the first target and ₹10,500 for the second target, showcasing its market leadership.
Apollo Hospital Share Price Target 2029
| Year | 1st Target | 2nd Target |
| 2029 | ₹11200 | ₹11750 |
The company is likely to continue benefiting from the growing healthcare market in 2029. The share price is expected to achieve a first target of ₹11,200 and a second target of ₹11,750, fueled by its wide-reaching healthcare network and innovation.
Apollo Hospital Share Price Target 2030
| Year | 1st Target | 2nd Target |
| 2030 | ₹12500 | ₹13250 |
By 2030, Apollo Hospitals is poised to expand its global presence and strengthen its position as a top healthcare provider. The share price is expected to reach ₹12,500 for the first target and ₹13,250 for the second target, reflecting strong business fundamentals.
Apollo Hospital Share Price Target 2035
| Year | 1st Target | 2nd Target |
| 2035 | ₹17500 | ₹19600 |
Over the next decade, Apollo Hospitals is expected to see significant growth driven by its continuous investment in healthcare infrastructure and services. By 2035, the share price is projected to hit ₹17,500 for the first target and ₹19,600 for the second target.
Read More: Dr Lal PathLabs Share Price Target 2025, 2030, 2035, 2040
Apollo Hospital Share Price Target 2040
| Year | 1st Target | 2nd Target |
| 2040 | ₹23000 | ₹25450 |
By 2040, Apollo Hospitals is likely to maintain its dominant position in the healthcare industry, delivering substantial returns for long-term investors. The share price is expected to achieve a first target of ₹23,000 and a second target of ₹25,450, reflecting its strong future growth potential.
Apollo Hospitals Ltd Fundamentals
| Metric | Value |
| Market Cap | ₹1,02,467 Cr |
| P/E Ratio (TTM) | 86.61 |
| P/B Ratio | 13.67 |
| Industry P/E | 71.91 |
| Debt to Equity | 0.98 |
| ROE (Return on Equity) | 15.77% |
| EPS (TTM) | 82.28 |
| Dividend Yield | 0.22% |
| 52 Week High | ₹7545 |
| 52 Week Low | ₹5284 |
| Book Value | 521.15 |
| Face Value | ₹5 |
Apollo Hospitals Ltd Financial Results
| All in ₹Cr. | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
| Sales | 10,560 | 14,663 | 16,612 | 19,059 | 20,469 |
| Expenses | 9,420 | 12,474 | 14,548 | 16,665 | 17,725 |
| Operating Profit | 1,140 | 2,189 | 2,065 | 2,394 | 2,745 |
| OPM % | 11% | 15% | 12% | 13% | 13% |
| Other Income | 103 | 368 | 75 | 105 | 158 |
| Interest | 449 | 379 | 381 | 449 | 466 |
| Depreciation | 573 | 601 | 615 | 687 | 719 |
| Profit before tax | 221 | 1,578 | 1,144 | 1,362 | 1,719 |
| Tax % | 38% | 30% | 22% | 33% | |
| Net Profit | 137 | 1,108 | 844 | 935 | 1,224 |
| EPS in Rs | 10.46 | 73.42 | 56.97 | 62.50 | 82.28 |
| Dividend Payout % | 29% | 16% | 26% | 26% |
Apollo Hospitals Ltd Balance Sheet
| All in ₹Cr. | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
| Equity Capital | 72 | 72 | 72 | 72 | 72 |
| Reserves | 4,531 | 5,551 | 6,126 | 6,864 | 7,429 |
| Borrowings | 4,160 | 4,068 | 4,332 | 5,333 | 7,371 |
| Other Liabilities | 2,629 | 3,570 | 3,886 | 4,474 | 4,676 |
| Total Liabilities | 11,392 | 13,261 | 14,416 | 16,742 | 19,548 |
| Fixed Assets | 6,778 | 8,296 | 8,520 | 9,664 | 10,201 |
| CWIP | 234 | 46 | 610 | 873 | 1,042 |
| Investments | 1,343 | 816 | 574 | 986 | 1,012 |
| Other Assets | 3,037 | 4,104 | 4,712 | 5,219 | 7,293 |
| Total Assets | 11,392 | 13,261 | 14,416 | 16,742 | 19,548 |
Apollo Hospitals Ltd Shareholding Pattern
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
| Promoters | 29.82% | 29.33% | 29.33% | 29.33% | 29.33% |
| FIIs | 54.51% | 50.81% | 46.96% | 45.63% | 45.37% |
| DIIs | 9.25% | 12.93% | 17.76% | 19.55% | 19.94% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| Public | 6.20% | 6.70% | 5.72% | 5.26% | 5.12% |
| No. of Shareholders | 67,091 | 1,26,226 | 1,31,937 | 1,30,664 | 1,19,245 |
Apollo Hospitals Dividend History From 2000 to 2024
| Announcement Date | Ex-Dividend Date | Dividend Type | Dividend (Rs) |
| 14 May, 2024 | 05 Jul, 2024 | Final | 6.00 |
| 09 May, 2023 | 14 Jul, 2023 | Final | 4.00 |
| 10 May, 2023 | 14 Jul, 2023 | Special | 0.50 |
| 12 May, 2022 | 16 Jun, 2022 | Final | 3.25 |
| 12 May, 2021 | 15 Jul, 2021 | Final | 3.50 |
| 24 Feb, 2020 | 04 Mar, 2020 | Interim | 3.00 |
| 09 May, 2019 | 23 Jul, 2019 | Final | 3.25 |
| 10 May, 2018 | 18 Jul, 2018 | Final | 3.00 |
| 05 May, 2017 | 27 Jun, 2017 | Final | 3.00 |
| 11 May, 2016 | 01 Aug, 2016 | Final | 2.00 |
| 12 May, 2015 | 04 Aug, 2015 | Final | 2.00 |
| 15 May, 2014 | 17 Jul, 2014 | Final | 0.75 |
| 10 May, 2013 | 18 Jul, 2013 | Final | 0.50 |
| 10 May, 2012 | 30 Jul, 2012 | Final | 0.50 |
| 11 May, 2011 | 26 Jul, 2011 | Final | 0.50 |
| 31 May, 2010 | 14 Jul, 2010 | Final | 0.75 |
| 04 May, 2009 | 29 Jun, 2009 | Final | 0.45 |
| 09 May, 2008 | 27 Jun, 2008 | Final | 0.50 |
| 12 Mar, 2007 | 23 Mar, 2007 | Interim | 4.50 |
| 05 May, 2006 | 21 Aug, 2006 | Final | 4.50 |
| 07 Jun, 2005 | 29 Jun, 2005 | Final | 4.50 |
| 19 May, 2004 | 28 Jun, 2004 | Final | 4.50 |
| 09 May, 2003 | 30 Jun, 2003 | Final | 4.50 |
Apollo Hospitals Split History
| Announcement Date | Ex-Split Date | Old FV | New FV | Remarks |
| 01 May, 2007 | 17 Aug, 2007 | 10 | 1 | For every share held, the holder will receive 10 shares post the split adjustment. |
Apollo Hospitals Ltd Peers comparison
| Name | P/E | Mar Cap ₹Cr. | Div Yld% | NP Qtr ₹Cr. | ROCE% |
| Apollo Hospitals | 87.92 | 104046.23 | 0.22 | 395.70 | 15.11 |
| Max Healthcare | 97.76 | 103488.31 | 0.15 | 281.81 | 16.00 |
| Fortis Health. | 78.05 | 53688.81 | 0.14 | 193.08 | 10.34 |
| Global Health | 63.98 | 31220.58 | 0.00 | 130.81 | 19.32 |
| Poly Medicure | 98.74 | 29105.82 | 0.11 | 87.45 | 23.62 |
| Narayana Hrudaya | 34.49 | 26932.72 | 0.30 | 198.80 | 26.54 |
| Dr Lal Pathlabs | 61.82 | 24826.39 | 0.81 | 130.80 | 25.17 |
FAQs
Q.1. What is the share price target for Apollo Hospitals in 2025?
Ans: The expected share price target for Apollo Hospitals in 2025 is ₹7850 as the first target and ₹8100 as the second target. This reflects consistent growth in the healthcare and hospital services sector.
Q.2. What are the projected share price targets for Apollo Hospitals in 2026?
Ans: For 2026, the share price is expected to reach ₹8550 as the first target and ₹8750 as the second target, driven by expanded service offerings and strong market presence in India and abroad.
Q.3. What is the anticipated share price target for Apollo Hospitals in 2027?
Ans: In 2027, the projected share price is ₹9150 as the first target and ₹9400 as the second target, supported by new hospitals and healthcare initiatives, alongside digital healthcare solutions.
Q.4. What are the share price targets for Apollo Hospitals in 2028?
Ans: The expected share price targets for 2028 are ₹10100 as the first target and ₹10500 as the second target, fueled by the continued demand for quality healthcare and Apollo’s growing network.
Q.5. What is the forecast for Apollo Hospitals’s share price in 2029?
Ans: For 2029, the share price is anticipated to reach ₹11200 as the first target and ₹11750 as the second target, reflecting the company’s expansion in both domestic and international markets.
Q.6. What are the share price targets for Apollo Hospitals in 2030?
Ans: By 2030, the share price is expected to achieve ₹12500 as the first target and ₹13250 as the second target, supported by healthcare industry growth, strong infrastructure, and new technological advancements in medical services.
Q.7. What are the long-term share price targets for Apollo Hospitals in 2035?
Ans: For 2035, the share price is expected to reach ₹17500 as the first target and ₹19600 as the second target, fueled by the continued rise in healthcare consumption and Apollo Hospitals’ strong brand.
Q.8. What is the share price target for Apollo Hospitals in 2040?
Ans: By 2040, the share price is anticipated to reach ₹23000 as the first target and ₹25450 as the second target, reflecting long-term growth potential in the healthcare industry, both in India and globally.
Q.9. Who is the current CEO of Apollo Hospitals?
Ans: The President and CEO of Apollo Hospitals’ Hospitals Division is Dr. Madhu Sasidhar, who was appointed in March 2024. He succeeded Dr. K Hari Prasad, who retired after 27 years of service.
Q.10. What is the NSE & BSE code for Apollo Hospitals?
Ans: Apollo Hospitals Enterprise Ltd. is listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). The company’s stock code on the NSE is APOLLOHOSP (NSE code: 508869), while its code on the BSE is APOLLOHOSP (BSE code: 500438).
TradeWatch360 is a premier platform dedicated to providing real-time insights, trends, and updates in the stock market. It is designed to support both new and seasoned investors by delivering timely and actionable information across a range of asset classes, including stocks, futures, commodities, and global markets.